TC-O 9311

1 1

Selleck Chemicals

S6976-5MG

€166,00 EUR
€166,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

TC-O 9311 is an agonist of GPR used in studies of GPCR Signaling. It is especially relevant in cell signaling and endocrinology models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

By activating GPR, TC-O 9311 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cell signaling and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving GPR
  • Pathway perturbation studies connected to GPCR Signaling
  • Agonist-response and downstream signaling studies
  • GPCR pharmacology, ligand-binding, and signaling assays

Overall, TC-O 9311 is appropriate when a defined chemical perturbant is needed to connect GPR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cell signaling and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
GPR
Target Class:
GPCR
Pathways:
GPCR Signaling
Research Area:
Cell Signaling • Endocrinology
CAS No.:
444932-31-4
Molecular Weight:
365.38
Formula:
C₂₀H₁₉N₃O₄
SMILES:
COC1=CC(=CC(=C1)C(=O)NNC(=O)NC2=C3C=CC=CC3=CC=C2)OC
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.